Julie Graff

Associate Professor

  • 689 Citations
  • 11 h-Index
20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Julie Graff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Taxoids Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

  • 689 Citations
  • 11 h-Index
  • 29 Article
  • 5 Review article
  • 1 Editorial
1 Citation (Scopus)
Genetic Testing
Prostatic Neoplasms
Clinical Trials
Genetic Counseling
Neoplasms
1 Citation (Scopus)

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nickols, N. G., Nazarian, R., Zhao, S. G., Tan, V., Uzunangelov, V., Xia, Z., Baertsch, R., Neeman, E., Gao, A. C., Thomas, G., Howard, L., De Hoedt, A. M., Stuart, J., Goldstein, T., Chi, K., Gleave, M. E., Graff, J., Beer, T. T., Drake, J. M., Evans, C. P. & 11 others, Aggarwal, R., Foye, A., Feng, F. Y., Small, E. J., Aronson, W. J., Freedland, S. J., Witte, O. N., Huang, J., Alumkal, J., Reiter, R. E. & Rettig, M. B., Jan 1 2019, In : Prostate Cancer and Prostatic Diseases.

Research output: Contribution to journalArticle

Open Access
Castration
Mitogen-Activated Protein Kinase Kinases
Prostatic Neoplasms
Therapeutics
Phosphotransferases

The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone

Hussain, A., Lee, R. J., Graff, J. & Halabi, S., Jul 1 2019, In : Critical Reviews in Oncology/Hematology. 139, p. 108-116 9 p.

Research output: Contribution to journalReview article

Open Access
Quality of Life
Clinical Trials
Neoplasm Metastasis
Bone and Bones
Survival
187 Citations (Scopus)

Apalutamide treatment and metastasis-free survival in prostate cancer

Smith, M. R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B. A., Graff, J., Olmos, D., Mainwaring, P. N., Lee, J. Y., Uemura, H., Lopez-Gitlitz, A., Trudel, G. C., Espina, B. M., Shu, Y., Park, Y. C., Rackoff, W. R., Yu, M. K. & Small, E. J., Apr 12 2018, In : New England Journal of Medicine. 378, 15, p. 1408-1418 11 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Placebos
Neoplasm Metastasis
Survival
Castration
14 Citations (Scopus)

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

Saad, F., Cella, D., Basch, E., Hadaschik, B. A., Mainwaring, P. N., Oudard, S., Graff, J., McQuarrie, K., Li, S., Hudgens, S., Lawson, J., Lopez-Gitlitz, A., Yu, M. K., Smith, M. R. & Small, E. J., Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1404-1416 13 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Placebos
Quality of Life
Androgens